Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells

Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells

Molecular characterization is currently a key step in NSCLC therapy selection. Circulating tumor cells (CTC) are excellent candidates for downstream analysis, but technology is still lagging behind. In this work, we show that the mutational status of NSCLC can be assessed on hypermetabolic CTC, dete...

Full description

Bibliographic Details
Main Authors: Matteo Turetta, Michela Bulfoni, Giulia Brisotto, Gianpiero Fasola, Andrea Zanello, Eva Biscontin, Laura Mariuzzi, Agostino Steffan, Carla Di Loreto, Daniela Cesselli, Fabio Del Ben
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Cancers
Subjects:
CTC
metabolism
glucose uptake
non-small cell lung cancer
liquid biopsy
Online Access:http://www.mdpi.com/2072-6694/10/8/270

Internet

http://www.mdpi.com/2072-6694/10/8/270

Similar Items